20.2
수축성 심부전(HFrEF, 심박출률 감소 심부전이라고도 함)은 가장 흔한 유형의 심실세동입니다. 심실에서 펌핑되는 혈액량이 감소합니다. 대동맥궁과 경동맥동에는 혈압 감소를 감지하는 압력수용체가 있어 교감신경계(SNS)가 에피네프린과 노르에피네프린을 분비하도록 합니다.…
수축기 심부전의 병태생리학은 좌심실이 감소된 혈액량을 펌핑하는 것으로 시작됩니다.
대동맥궁과 경동맥동에 있는 압력수용기는 이러한 감소를 감지하여 교감신경계가 에피네프린과 노르에피네프린을 방출하도록 하여 심박수와 수축성을 높입니다.
교감신경 자극은 또한 피부, 위장관 및 신장에서 혈관 수축을 유발합니다.
낮은 심박출량과 교감신경 활성화로 인한 신장 관류 감소는 레닌 방출을 유발합니다.
레닌은 안지오텐시노겐을 안지오텐신 I으로 전환하고, 안지오텐신 I은 폐의 안지오텐신 전환 효소에 의해 안지오텐신 II로 전환됩니다.
안지오텐신 II는 혈압과 후부하를 증가시키고 알도스테론 분비를 자극하여 나트륨과 체액 저류를 유발합니다.
또한, 과도하게 팽창된 심장실에서 분비되는 나트륨 이뇨 펩타이드는 혈관 확장과 이뇨를 촉진하지만 종종 불충분합니다.
결국, 심장에 가해지는 업무량이 증가하면 심근 수축이 감소하여 심실 확장, 비대, 리모델링, 조기 심근 세포 사멸로 이어져 이완기 심부전을 초래합니다.
View the full transcript and gain access to JoVE Core videos
Q1: What triggers the sympathetic nervous system response in systolic heart failure?
Baroreceptors in the aortic arch and carotid sinuses detect reduced blood pressure from decreased cardiac output. This triggers the sympathetic nervous system to release epinephrine and norepinephrine, which increase heart rate and contractility to support the weakened myocardium and restore blood pressure.
Q2: How does reduced renal perfusion activate the renin-angiotensin-aldosterone system?
Low cardiac output and sympathetic activation cause vasoconstriction in the kidneys, reducing renal perfusion. This triggers renin release, which converts angiotensinogen to angiotensin I. Angiotensin-converting enzyme in the lungs then converts angiotensin I to angiotensin II, a potent vasoconstrictor that raises blood pressure and afterload.
Q3: What role does aldosterone play in fluid overload during heart failure?
Angiotensin II stimulates the adrenal cortex to release aldosterone, which causes renal tubules to retain sodium and fluid. This increases blood volume and preload, contributing to the fluid overload characteristic of heart failure and further burdening the weakened heart muscle.
Q4: Why are natriuretic peptides insufficient to counteract heart failure progression?
Natriuretic peptides like BNP and ANP are released from distended cardiac chambers to promote vasodilation and diuresis. However, their effects are typically insufficient to counteract the adverse effects of prolonged sympathetic activation, renin-angiotensin-aldosterone system activation, and other neurohormonal mechanisms driving heart failure.
Q5: How does increased cardiac workload lead to ventricular dilation and hypertrophy?
As myocardial contractility decreases, end-diastolic blood volume increases, stretching myocardial fibers and causing ventricular dilation. The heart responds to increased workload by thickening its muscle, a process called ventricular hypertrophy. These structural changes constitute ventricular remodeling, which further impairs cardiac function.
Q6: What is the vicious cycle of heart failure and how does it progress?
Low cardiac output triggers compensatory mechanisms that increase the heart's workload, worsening the condition. Neurohormones like angiotensin II promote myocardial hypertrophy and fibrosis, causing cell death and loss of contractility. This cycle eventually leads to diastolic heart failure, where a stiff ventricle resists filling and decreases cardiac output.
Q7: What adverse effects result from prolonged sympathetic nervous system activation?
Prolonged sympathetic activation causes vasoconstriction in the skin, gastrointestinal tract, and kidneys, reducing perfusion to vital organs. This triggers renin release and activates the renin-angiotensin-aldosterone system, leading to increased blood pressure, fluid retention, and elevated preload and afterload that further stress the failing heart.